» Articles » PMID: 28837251

Elevated Expression of JAM-A Promotes Neoplastic Properties of Lung Adenocarcinoma

Overview
Journal Cancer Sci
Specialty Oncology
Date 2017 Aug 25
PMID 28837251
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

A cell-cell adhesion protein, junctional adhesion molecule-A (JAM-A), has been shown to be involved in neoplasia of various organs. However, the fundamental role of JAM-A in tumorigenesis is still under debate because dysregulated expression of this protein has distinct effects, playing opposite roles in carcinogenesis depending on the target tissues. In the present study, we found elevated levels of JAM-A expression in lung adenocarcinoma and its preinvasive lesions, including atypical adenomatous hyperplasia and adenocarcinoma in situ by immunohistochemistry. We also showed that suppression of constitutive JAM-A expression conferred target cells with increased susceptibility to apoptosis in lung adenocarcinoma cells. Consequently, inhibition of JAM-A activity decreased colony-forming capability in vitro and tumorigenicity in vivo. The transformed phenotype following suppression of JAM-A expression was sufficient to reduce motile and invasive capacities. Importantly, knockout of JAM-A had striking effects on cells. Our observations suggest that increased expression of JAM-A promotes neoplasia of lung adenocarcinoma. In addition, an anti-JAM-A antibody efficiently reduced cell proliferation and provoked apoptosis, indicating the potential feasibility of JAM-A-inhibitory cancer therapy.

Citing Articles

Identification and Validation of JAM-A as a Novel Prognostic and Immune Factor in Human Tumors.

Ren T, Zheng Y, Liu F, Liu C, Zhang B, Ren H Biomedicines. 2024; 12(7).

PMID: 39061997 PMC: 11275048. DOI: 10.3390/biomedicines12071423.


Multilayered proteomics reveals that JAM-A promotes breast cancer progression via regulation of amino acid transporter LAT1.

Magara K, Takasawa A, Takasawa K, Aoyama T, Ota M, Kyuno D Cancer Sci. 2024; 115(9):3153-3168.

PMID: 38943512 PMC: 11462982. DOI: 10.1111/cas.16259.


Vitamin D-metabolizing enzyme CYP24A1 affects oncogenic behaviors of oral squamous cell carcinoma and its prognostic implication.

Nakamori Y, Takasawa A, Takasawa K, Kyuno D, Ono Y, Magara K Med Mol Morphol. 2024; 57(3):185-199.

PMID: 38772955 DOI: 10.1007/s00795-024-00387-y.


Impact of the Junction Adhesion Molecule-A on Asthma.

An M, Lee P, Choi S, Hwang D, Kim J, Park M Yonsei Med J. 2023; 64(6):375-383.

PMID: 37226564 PMC: 10233001. DOI: 10.3349/ymj.2022.0503.


The activation of EP300 by F11R leads to EMT and acts as a prognostic factor in triple-negative breast cancers.

Li C, Fang C, Chan M, Lu P, Ger L, Chu J J Pathol Clin Res. 2023; 9(3):165-181.

PMID: 36782375 PMC: 10073929. DOI: 10.1002/cjp2.313.


References
1.
Tsukita S, Furuse M, Itoh M . Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol. 2001; 2(4):285-93. DOI: 10.1038/35067088. View

2.
Mitchell L, Ward C, Kwon M, Mitchell P, Quintero D, Nusrat A . Junctional adhesion molecule A promotes epithelial tight junction assembly to augment lung barrier function. Am J Pathol. 2014; 185(2):372-86. PMC: 4305184. DOI: 10.1016/j.ajpath.2014.10.010. View

3.
Ghidoni I, Chlapanidas T, Bucco M, Crovato F, Marazzi M, Vigo D . Alginate cell encapsulation: new advances in reproduction and cartilage regenerative medicine. Cytotechnology. 2008; 58(1):49-56. PMC: 2593756. DOI: 10.1007/s10616-008-9161-0. View

4.
Koshiba H, Hosokawa K, Kubo A, Tokumitsu N, Watanabe A, Honjo H . Junctional adhesion molecule A [corrected] expression in human endometrial carcinoma. Int J Gynecol Cancer. 2009; 19(2):208-13. DOI: 10.1111/IGC.0b013e31819bc6e9. View

5.
Kanda Y . Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant. 2012; 48(3):452-8. PMC: 3590441. DOI: 10.1038/bmt.2012.244. View